United Kingdom-BELFAST: Purchase of Secukinumab (Cosentyx)

Type of document: Contract award
Country: United Kingdom
Publication Ref: (2021/S 000-014292/EN)
Nature of contract: Supply contract
Procedure: Negotiated without a call for competition
Type of bid required: Not applicable

Contract award notice
Supplies

Section I: Contracting authority
I.1) Name and addresses
Official name: BELFAST HEALTH AND SOCIAL CARE TRUST
Postal address: LISBURN ROAD
Town: BELFAST
Postal code: BT97AB
Country: United Kingdom
Contact Person: Norma Moore
Email: norma.moore@belfasttrust.hscni.net
Internet address(es):
Main address:

I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health

Section II: Object
II.1) Scope of the procurement
II.1.1) Title: Purchase of Secukinumab (Cosentyx)

Reference number: DACPM2021-46
II.1.2) Main CPV code: 33600000
II.1.3) Type of contract Supplies
II.1.4) Short Description: Purchase of Secukinumab (Cosentyx)
II.1.6) Information about lots:
The contract is divided into lots: no
II.1.7) Total value of the procurement(excluding VAT)
Value:4090000
Currency:GBP
II.2) Description
II.2.3) Place of performance
Nuts code:
Main site or place of performance:Belfast Health and Social Care Trust

II.2.4) Description of the procurement
Purchase of Secukinumab (Cosentyx)

II.2.5)Award criteria

II.2.11) Information about options
Options no
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no

Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below

1.Justification for the choice of the negotiated procedure without prior publication of a call for competition in accordance with Article
32 of Directive 2014/24/EU
The works, supplies or services can be provided only by a particular economic operator for the following reason:
protection of exclusive rights, including intellectual property rights

3.Explanation
Please explain in a clear and comprehensive manner why the award of the contract without prior publication in the Official Journal of the European Union
is lawful, by stating the relevant facts and, as appropriate, the conclusions of law in accordance with the directive:
Secukinumab (Cosentyx) is a branded patent protected medicine that is only available from Novartis via their homecare provider Healthcare at Home.

IV.1.3) Information about a framework agreement or a dynamic purchasing system
IV.1.8) Information about the Government Procurement Agreement(GPA)
The procurement is covered by the Government Procurement Agreement: yes
IV.2) Administrative information
Section V: Award of contract
Contract No: DACPM2021-46
Title: Purchase of Secukinumab (Cosentyx)

A contract/lot is awarded yes
V.2) Award of contract
V.2.1) Date of conclusion of the contract:2021-06-01
V.2.2) Information about tenders
Number of tenders received:1
The contract has been awarded to a group of economic operators: no
V.2.3) Name and address of the contractor
Official name: Healthcare at Home
Postal address: 5th Avenue, Centrum 100
Town: Burton on Trent
Postal code: DE14 2WS
Country: United Kingdom
Nuts code:
Internet address:
The contractor is an SME no

V.2.4) Information on value of the contract/lot(excluding VAT)
Initial estimated total value of the contract/lot: 4090000
Total value of the contract/lot:4090000
Currency:GBP

Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
Official name: Belfast Health and Social Care Trust
Postal address: Dorothy Gardiner Unit, Knockbracken Healthcare Park
Town: Belfast
Postal code: BT8 8BH
Country: United Kingdom
E-mail: norma.moore@belfasttrust.hscni.net
Internet address:

VI.5) Date of dispatch of this notice:
2021-06-23